Dr Reddys Laboratories Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 6,903.90 | 6,059 | 5,317.50 |
| Operating Expense | 3,974.70 | 3,888.20 | 3,726.20 |
| Net Profit | 1,882.10 | 1,417.20 | 1,034.80 |
| Net Profit Margin | 27.26 | 23.39 | 19.46 |
| Earning Per Share | 113 | 85.10 | 62.14 |
| EBIDTA | 2,873.80 | 2,140.70 | 1,557.10 |
| Effective Tax Rate | 24.01 | 21.49 | 16.98 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 6903.90 |
| Operating Expense | 3974.70 |
| Net Profit | 1882.10 |
| Net Profit Margin | 27.26 |
| Earning Per Share | 113.00 |
| EBIDTA | 2873.80 |
| Effective Tax Rate | 24.01 |
Invest in Dr Reddys Laboratories Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 19,483.80 | 16,962.50 | 14,405.20 |
| Operating Expenses Annual | 13,557.40 | 12,747.70 | 11,811.10 |
| Operating Profit Annual | 6,788.70 | 4,806.10 | 3,076.10 |
| Interest Annual | 21.80 | 16.90 | 38 |
| Depreciation | 758.10 | 698.10 | 621.40 |
| Net Profit Annual | 4,342 | 2,612.80 | 1,623.20 |
| Tax Annual | 1,449.30 | 1,253.20 | 600.60 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 19,483.80 |
| Operating Expenses Annual | 13,557.40 |
| Operating Profit Annual | 6,788.70 |
| Interest Annual | 21.80 |
| Depreciation | 758.10 |
| Net Profit Annual | 4,342 |
| Tax Annual | 1,449.30 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 112.30 | 1,159.50 | 1,305.40 |
| Cash Flow from Operations | 3,449.70 | 5,052.90 | 1,338.70 |
| Cash Flow from Investing | -3,428.70 | -3,403.20 | -1,990.10 |
| Cash Flow from Financing | 68.10 | -2,696.90 | 505.50 |
| Cash Flow at the End | 201.40 | 112.30 | 1,159.50 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 112.30 |
| Cash Flow from Operations | 3,449.70 |
| Cash Flow from Investing | -3,428.70 |
| Cash Flow from Financing | 68.10 |
| Cash Flow at the End | 201.40 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 34.84 | 28.33 | 21.35 |
| PBIT Margin (%) | 29.84 | 22.89 | 15.70 |
| PBT Margin (%) | 28.47 | 21.54 | 15.29 |
| Net PROFIT Margin (%) | 22.29 | 15.40 | 11.27 |
| Return On Networth / Equity (%) | 19.42 | 13.46 | 9.19 |
| Return On Networth /Employed (%) | 25.40 | 18.82 | 11.63 |
| Return On Assets (%) | 18.94 | 12.63 | 8.34 |
| Total Debt / Equity (X) | 0.02 | 0.06 | 0.10 |
| Asset Turnover Ratio (%) | 0.85 | 0.82 | 0.74 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 34.84 |
| PBIT Margin (%) | 29.84 |
| PBT Margin (%) | 28.47 |
| Net PROFIT Margin (%) | 22.29 |
| Return On Networth / Equity (%) | 19.42 |
| Return On Networth /Employed (%) | 25.40 |
| Return On Assets (%) | 18.94 |
| Total Debt / Equity (X) | 0.02 |
| Asset Turnover Ratio (%) | 0.85 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 7,628.20 | 7,220.60 | 6,164.40 |
| Total Current Assets Annual | 17,815.90 | 13,788.30 | 13,491.30 |
| Non Current Assets Annual | 12,543.40 | 11,586.50 | 11,004.30 |
| Total Shareholders Funds Annual | 24,240.80 | 20,474.20 | 18,336.20 |
| Total Assets Annual | 30,359.30 | 25,374.80 | 24,495.60 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 7,628.20 |
| Total Current Assets Annual | 17,815.90 |
| Non Current Assets Annual | 12,543.40 |
| Total Shareholders Funds Annual | 24,240.80 |
| Total Assets Annual | 30,359.30 |
EPS (INR)
Expected
75.28
Reported
75.40
Surprise
0.16%
Jun 2024
EPS beaten by 0.16%
Mar 2024
EPS beaten by 0.16%
Dec 2023
EPS beaten by 0.17%
